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Association between regional distributions of
SARS-CoV-2 seroconversion and out-of-hospital
sudden death during the ﬁrst epidemic outbreak in
New York
Kristie M. Coleman, RN, Moussa Saleh, MD, Stavros E. Mountantonakis, MD, FHRS
From the Department of Cardiac Electrophysiology, Lenox Hill Hospital, New York, New York.
BACKGROUND Increased incidence of out-of-hospital sudden
death (OHSD) has been reported during the coronavirus 2019
(COVID-19) pandemic. New York City (NYC) represents a unique opportunity to examine the epidemiologic association between the
two given the variable regional distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in its highly diverse
neighborhoods.
OBJECTIVE The purpose of this study was to examine the association between OHSD and SARS-CoV-2 epidemiologic burden during
the ﬁrst COVID-19 pandemic across the highly diverse neighborhoods of NYC.
METHODS The incidences of OHSD between March 20 and April 22,
2019, and between March 20 and April 22, 2020, as reported by the
Fire Department of New York were obtained. As a surrogate for viral
epidemiologic burden, we used percentage of positive SARS-CoV-2
antibody tests performed between March 3 and August 20, 2020.
Data were reported separately for the 176 zip codes of NYC. Correlation analysis and regression analysis were performed between the 2
measures to examine association.

Introduction
Reports of increased incidence of out-of-hospital sudden
death (OHSD) during the coronavirus 2019 (COVID-19)
pandemic have raised the question of a possible association
between severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) and malignant arrhythmias, traditionally
considered the common mechanism of sudden death.1,2
In addition to the previously reported temporal association
between COVID-19 and OHSD during the epidemic surge,1,2
a similar association in the regional distribution of their incidence is expected. New York City (NYC) represents a unique
opportunity to examine the epidemiologic association
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RESULTS Incidence of OHSD per 10,000 inhabitants and percentage of SARS-CoV-2 seroconversion were highly variable across NYC
neighborhoods, varying from 0.0 to 22.9 and 12.4% to 50.9%,
respectively. Correlation analysis showed a moderate positive correlation between neighborhood data on OHSD and percentage of positive antibody tests to SARS-CoV-2 (Spearman r 0.506; P ,.001).
Regression analysis showed that seroconversion to SARS-CoV-2
and OHSD in 2019 were independent predictors for OHSD during
the ﬁrst epidemic surge in NYC (R2 5 0.645).
CONCLUSION The association in geographic distribution between
OHSD and SARS-CoV-2 epidemiologic burden suggests either a causality between the 2 syndromes or the presence of local determinants affecting both measures in a similar fashion.
KEYWORDS Arrhythmias; COVID-19 pandemic; Epidemiologic
burden; Out-of-hospital sudden death; SARS-CoV-2 antibodies
(Heart Rhythm 2021;18:215–218)
All rights reserved.
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between the two given the variable regional distribution of
SARS-CoV-2 in its highly diverse neighborhoods.3

Methods
Serologic testing of the population post epidemic outbreak is
a reliable surrogate for viral epidemiologic burden that is less
likely to be affected by inherent limitations of assessing
COVID-19 incidence during the epidemic crisis, including
limited testing, poor access to care, and inaccurate documentation. Therefore, we used the results of all antibody tests reported to the NYC Department of Health between March 3
and August 20, 2020, in NYC. We analyzed results for 176
NYC zip codes after excluding 8 zip codes that represented
commercial districts. Testing was voluntary and free of
charge for all NYC residents.4 The NYC Department of
Health requires mandatory reporting of serologic testing results, and data presented here are reﬂective of all reported
electronic laboratory results in NYC.
https://doi.org/10.1016/j.hrthm.2020.11.022
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In order to examine potential confounders of socioeconomic characteristics of each zip code on the rate of testing,
we used data from the American Community Survey (5-year
estimates) 2014–2018 conducted by the United States
Census Bureau. We used the following 5 socioeconomic
characteristics for our comparisons—percentage of population with (1) age over 65; (2) black race or Hispanic ethnicity;
(3) no medical insurance; (4) education less than high school;
and (5) immigration status of noncitizen.
Incidence of OHSD was obtained from the Fire Department of New York (FDNY) during the COVID-19 epidemic
outbreak in NYC (period between March 20 and April 22,
2020). We deﬁne OHSD as patients who were pronounced
dead on the scene by emergency medical personnel responding to a call that was classiﬁed as sudden cardiac arrest according to FDNY criteria.1 An historical cohort was also
obtained for the same time period a year earlier.
One-way analysis of variance was used to detect the inﬂuence of the 5 socioeconomic characteristics on serologic
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testing. Correlation analysis (Spearman r) was used to
show correlation at a signiﬁcance level of 0.05. Linear regression analysis was used to identify independent predictors of
OHSD in 2020. Statistical analyses were performed using
SPSS Version 27.0 (IBM, Armonk, NY). The research reported in this study adhered to Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines.

Results
Between March 3 and August 20, 2020, a total of 1,763,251
people had a serologic test for SARS-CoV-2 in NYC. Distribution of testing per 10,000 inhabitants varied signiﬁcantly
across the 176 zip codes, varying from 1231 to 5387
(12.3%–53.9% of the population). One-way analysis of variance failed to detect signiﬁcant differences in testing rate
among quartiles of the 5 socioeconomic characteristics.
Among those tested, 457,956 (24.7%) were reported to be

Figure 1 A: Geographic distribution of incidence of out-of-hospital sudden death (OHSD) per 10,000 inhabitants (historical control) (March 22 to April 22,
2019) in New York City. B: Geographic distribution of incidence of OHSD per 10,000 inhabitants during coronavirus 2019 (COVID-19) outbreak (March 22 to
April 22, 2020) in New York City. C: Scatterplot depicting neighborhood-level association between OHSD during the COVID-19 outbreak and percentage of
positive tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies.
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seropositive to SARS-CoV-2 antibody test. Percentage of
seroconversion also was highly variable across NYC neighborhoods, varying from 12.4% to 50.9 %.
OHSD per 10,000 people during the epidemic outbreak in
2020 also followed a diverse geographic distribution in NYC,
with rates between 0.0 and 22.9. As previously reported,
there was a 2.89-fold increase in the incidence of OHSD in
NYC compared to 2019 for the same period.1 Correlation
analysis suggested a similar geographic distribution in the
incidence of OHSD throughout NYC neighborhoods (r 5
0.715; P ,.001) between 2019 and 2020. Regional distribution of OHSD during the COVID-19 outbreak correlated with
that of seroconversion to SARS-CoV-2 antibody test (r 5
0.506; P ,.001). The geographic distribution of OHSD
across the neighborhoods of NYC during the COVID-19
outbreak and the association between zip code–level
OHSD and SARS-CoV-2 seroconversion are depicted in
Figure 1. We used zip code–speciﬁc socioeconomic predictors (categorical variables), percentage of positive antibody
tests, and OHSD during the control period in 2019 in regression models to identify predictors for OHSD during the
pandemic. In our strongest model, seroconversion to
SARS-CoV-2 (b 5 0.757) and OHSD in 2019 (b 5 2.88)
were found to be independent predictors of OHSD during
the ﬁrst pandemic surge in NYC (R2 5 0.645; P ,.001).

Discussion
We report that the highly diverse regional distribution of
OHSD during the COVID-19 pandemic surge follows the
geographic distribution of seroconversion to SARS-CoV-2
in NYC. This ﬁnding adds to the previously reported temporal association between OHSD and COVID-19 presumed
deaths1 and further supports an association between OHSD
and SARS-CoV-2 epidemiologic burden. Whether this association is causative or there are factors that affect similarly the
geographic distribution of both is unclear. Malignant arrhythmias that have been reported in the inpatient setting5 are
potentiated by hypoxia, systemic inﬂammatory response,
and metabolic disarray often seen with COVID-19.6 In addition, the presence of regional myocardial inﬂammation is reported in patients who recovered from COVID-19, which can
constitute a potential substrate for the development of ventricular arrhythmias.7 Furthermore, the fulminant course of
respiratory failure and thromboembolism as described in
COVID-19 patients could result in the sudden demise of
these patients.8 Lai et al9 reported a temporal relationship between emergency calls for viral-related symptoms and
OHSD; however, the causative relationship between
COVID-19 and OHSD cannot be proved because the
COVID-19 status of those patients was unknown.
Conversely, regional socioeconomic factors are possible
confounders that could affect both the virus spread and the
increase of OHSD during a health care crisis. Lai et al9 reported higher incidence of older age, nonwhite race/ethnicity,
comorbidities, and physical limitations in patients with
OHSD during the COVID-19 epidemic. These factors have
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been shown to affect SARS-CoV-2 spread and outcomes,
as well as patients’ ability to access care in a timely
fashion.10–12
The signiﬁcant reduction in hospital admissions for
myocardial infarctions and stroke has been widely published
and postulated as the reason for the excess mortality not associated with COVID-19.13 Failure to present to the emergency
room due to fear may have had a detrimental impact on patients with myocardial infarction or stroke in either delaying
or not seeking care altogether. We previously reported the
relationship between an increase in OHSD and inpatient admissions for acute coronary syndromes.1
We present a moderate positive association between
geographic dispersion of seroconversion to SARS-CoV-2
and rate of OHSD during the pandemic and acknowledge
that future studies will need to explore a possible biological
link or elucidate whether this relationship is due to other confounding variables.

Study limitations
There is an implicit selection bias in all reported Department
of Health testing data related to availability of testing sites
and disease severity in individuals seeking testing. Available
data on the neighborhood level might not be able to detect
differences in socioeconomic factors that might inﬂuence
testing. Symptomatic individuals or those having close contact with a positive case may have preferentially sought out
antibody testing. The use of seroconversion as a surrogate
for COVID-19 could underrepresent the actual number of infected population due to a small percentage of nonresponders
and reported rapid decline in antibody titers post initial infection.14 In addition, results of seroconversion tests from
outside the surge window are included in our analysis; as
seroconversion is a marker of past infection from SARSCoV-2, we feel this is appropriate. FDNY data may have
underestimated the true incidence of OHSD for a minority
of neighborhoods where secondary private emergency services are used.

Conclusion
There was a moderate positive association between
geographic dispersion of seroconversion to SARS-CoV-2
and incidence of OHSD during the COVID-19 pandemic.
This is a hypothesis-generating ﬁnding about the causal relationship or lack thereof between the 2 syndromes.
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